home / stock / evo / evo news


EVO News and Press, Evotec SE From 01/22/24

Stock Information

Company Name: Evotec SE
Stock Symbol: EVO
Market: NASDAQ
Website: evotec.com

Menu

EVO EVO Quote EVO Short EVO News EVO Articles EVO Message Board
Get EVO Alerts

News, Short Squeeze, Breakout and More Instantly...

EVO - Evotec SE (EVO) Business Update Conference Call (Transcript)

2024-01-22 15:43:08 ET Evotec SE (EVO) Business Update Conference Call January 22, 2024, 09:00 AM ET Company Participants Volker Braun - SVP, Head of Global IR & ESG Iris Löw-Friedrich - Chairwoman Mario Polywka - Interim CEO Conference Call Partic...

EVO - Evotec SE: Invitation to Conference Call

HAMBURG, GERMANY / ACCESSWIRE / January 22, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) is going to hold a conference call to provide a statement as well as a business update on Monday, 22 January 2024. During the call, the Chairwoman of Evotec's...

EVO - Elevai Labs, Allakos, TransCode Therapeutics among healthcare movers

2024-01-16 10:00:59 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tu...

EVO - Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapies

EVOTEC JOINS FORCES WITH THE CROHN'S & COLITIS FOUNDATION'S IBD THERAPEUTICS INCUBATOR TO ADVANCE DRUG DISCOVERY AND IDENTIFY NOVEL THERAPIES FOR INFLAMMATORY BOWEL DISEASE ("IBD") THE COLLABORATION LEVERAGES EVOTEC'S END-TO-END INTEGRATED R&D PLATFORM TO ADVANCE DRUG DISCOVERY FOR T...

EVO - Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb

KEY SCIENTIFIC ACHIEVEMENT ADVANCES THE JOINT NEUROSCIENCE PIPELINE AND EARNS A PAYMENT OF US$ 25 M TO EVOTEC TO PROGRESS FURTHER RESEARCH HAMBURG, GERMANY / ACCESSWIRE / January 8, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) today announced...

EVO - How the (EVO) price action is used to our Advantage

2024-01-07 22:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

EVO - Why Is Mobileye (MBLY) Stock Down 26% Today?

2024-01-04 09:45:42 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Mobileye (NASDAQ: MBLY ) stock isn’t doing so hot on Thursday as investors digest the autonomous driving technologies company’s outlook for 2024 and preliminary 20...

EVO - Can TikTok Save Peloton (PTON) Stock?

2024-01-04 09:22:39 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Peloton (NASDAQ: PTON ) stock is on the rise Thursday as investors celebrate a new partnership between the fitness company and TikTok . This partnership has Peloton sett...

EVO - Why Is Evotec (EVO) Stock Down 12% Today?

2024-01-04 09:01:10 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Evotec (NASDAQ: EVO ) stock is falling on Thursday after the drug discovery and development partner announced the resignation of CEO Dr. Werner Lanthaler . According to a pr...

EVO - Evotec and Owkin enter AI-powered partnership to accelerate therapeutics pipeline in oncology

2024-01-04 03:33:18 ET More on Evotec SE Evotec: Attractive Spec 'Buy', But Merck KGaA Is Still Better Evotec SE (EVO) Q3 2023 Earnings Call Transcript Evotec SE 2023 Q3 - Results - Earnings Call Presentation Evotec partner Jingxin receives approval for EVT20...

Previous 10 Next 10